ANIP EBITDA | ANI PHARMACEUTICALS, INC

ANI PHARMACEUTICALS, INC (ANIP) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income $40.46M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $38.89M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $36.24M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $13.89M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2012-06-30 to 2022-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	$40.46M	(m)	$266.04M	(m)	$3.05M*	$56.67M*	(m)	$14.75M	$91.66M	$12.39M
2026-03-31	Reported	(m)	$38.89M	(m)	$237.46M	(m)	$6.07M	$58.38M	(m)	$10.60M	$73.66M	$10.73M
2025-09-30	Reported	(m)	$36.24M	(m)	$227.81M	(m)	$6.10M*	$44.05M*	(m)	$12.30M	$76.66M	$7.18M
2025-06-30	Reported	(m)	$13.89M	(m)	$211.37M	(m)	$4.01M*	$75.81M*	(m)	$16.54M	$81.77M	$1.98M
2025-03-31	Reported	(m)	$26.19M	(m)	$197.12M	(m)	$2.47M	$34.99M	(m)	$10.56M	$76.53M	$4.31M
2024-09-30	Reported	(m)	-$20.52M	(m)	$148.33M	(m)	$4.81M*	$12.47M*	(m)	$10.13M	$79.08M	-$7.33M
2024-06-30	Reported	(m)	$5.17M	(m)	$138.04M	(m)	$4.45M*	$17.41M*	(m)	$7.30M	$52.82M	$0.00
2024-03-31	Reported	(m)	$20.31M	(m)	$137.43M	(m)	$4.58M	$18.27M	(m)	$10.51M	$48.02M	$7.13M
2023-09-30	Reported	(m)	$17.95M	(m)	$131.83M	(m)	$1.74M*	$32.17M*	(m)	$11.12M	$42.01M	$1.57M
2023-06-30	Reported	(m)	$12.40M	(m)	$116.55M	(m)	$2.50M*	$20.63M*	(m)	$7.37M	$38.76M	-$996.00K
2023-03-31	Reported	(m)	$9.89M	(m)	$106.79M	(m)	$2.35M	$21.42M	(m)	$5.92M	$36.47M	$726.00K
2022-09-30	Reported	(m)	-$5.00M	(m)	$83.82M	(m)	$2.47M*	$3.62M*	(m)	$7.66M	$30.08M	-$3.62M
2022-06-30	Reported	(m)	-$12.91M	(m)	$73.86M	(m)	$1.32M*	-$11.48M*	(m)	$4.17M	$31.96M	-$3.90M
2022-03-31	Reported	-$4.64M	(m)	(m)	(m)	-7.19%	$1.95M	-$18.94M	(m)	$5.27M	$28.82M	-$5.77M
2021-12-31	Reported	-$10.04M	(m)	(m)	(m)	-16.48%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$7.78M	(m)	(m)	(m)	14.95%	$571.00K*	-$5.40M*	(m)	$2.46M	$17.18M	-$2.68M
2021-06-30	Reported	-$4.23M	(m)	(m)	(m)	-8.70%	$932.00K*	$241.00K*	(m)	$2.81M	$18.82M	-$4.04M
2021-03-31	Reported	$13.94M	(m)	(m)	(m)	25.57%	$698.00K	$20.67M	(m)	$2.97M	$17.59M	-$10.00K
2020-12-31	Reported	$11.23M	(m)	(m)	(m)	19.62%	(m)	(m)	(m)	(m)	(m)	$1.25M
2020-09-30	Reported	$14.16M	(m)	(m)	(m)	26.73%	$1.76M*	-$1.61M*	(m)	$2.94M	$15.72M	-$371.00K
2020-06-30	Reported	-$109,000.00	(m)	(m)	(m)	-0.22%	$725.00K*	$20.88M*	(m)	$3.04M	$21.21M	-$1.44M
2020-03-31	Reported	$3.34M	(m)	(m)	(m)	6.71%	$1.54M	$1.71M	(m)	$6.34M	$13.68M	-$2.85M
2019-12-31	Reported	$4.89M	(m)	(m)	(m)	10.20%	(m)	(m)	(m)	(m)	(m)	-$2.82M
2019-09-30	Reported	$16.8M	(m)	(m)	(m)	32.73%	$1.52M*	$21.79M*	(m)	$4.98M	$14.36M	$64.00K
2019-06-30	Reported	$18.76M	(m)	(m)	(m)	34.52%	$1.63M*	$4.74M*	(m)	$5.77M	$14.19M	-$653.00K
2019-03-31	Reported	$20.51M	(m)	(m)	(m)	38.77%	$1.77M	$14.29M	(m)	$4.37M	$13.28M	$469.00K
2018-12-31	Reported	$20.13M	(m)	(m)	(m)	35.24%	(m)	(m)	(m)	(m)	(m)	$1.91M
2018-09-30	Reported	$18.66M	(m)	(m)	(m)	36.81%	$1.37M*	$8.32M*	(m)	$4.67M	$11.77M	$1.33M
2018-06-30	Reported	$15.58M	(m)	(m)	(m)	32.95%	$1.09M*	$8.59M*	(m)	$5.14M	$9.96M	$726.00K
2018-03-31	Reported	$14.73M	(m)	(m)	(m)	31.69%	$2.28M	$22.93M	(m)	$2.10M	$8.96M	$592.00K
2017-12-31	Reported	$14.4M	(m)	(m)	(m)	30.46%	(m)	(m)	(m)	(m)	(m)	-$13.98M
2017-09-30	Reported	$16.43M	(m)	(m)	(m)	34.11%	$2.48M*	$17.08M*	(m)	$2.63M	$8.02M	-$1.65M
2017-06-30	Reported	$14.1M	(m)	(m)	(m)	31.49%	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Reported	$11.33M	(m)	(m)	(m)	30.94%	$2.14M	$6.53M	(m)	$1.62M	$7.29M	-$523.00K
2016-12-31	Reported	$7.11M	(m)	(m)	(m)	18.61%	(m)	(m)	(m)	(m)	(m)	$524.00K
2016-09-30	Reported	$13.89M	(m)	(m)	(m)	36.05%	$1.09M*	$1.08M*	(m)	$1.04M	$6.93M	-$2.50M
2016-06-30	Reported	$11.15M	(m)	(m)	(m)	35.58%	$719.00K*	$3.34M*	(m)	$764.00K	$7.63M	-$1.23M
2016-03-31	Reported	$10.28M	(m)	(m)	(m)	49.99%	$1.37M	$10.97M	(m)	$966.00K	$5.90M	-$1.54M
2015-12-31	Reported	$8.38M	(m)	(m)	(m)	46.46%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$10.5M	(m)	(m)	(m)	52.56%	$768.00K*	$10.24M*	(m)	$815.00K	$5.40M	$1.10M
2015-06-30	Reported	$9.83M	(m)	(m)	(m)	50.36%	$198.00K*	$1.21M*	(m)	$995.00K	$5.55M	$2.09M
2015-03-31	Reported	$10.89M	(m)	(m)	(m)	57.95%	$112.00K	$1.12M	(m)	$403.00K	$4.75M	$2.54M
2014-12-31	Reported	$12.05M	(m)	(m)	(m)	57.30%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$9.39M	(m)	(m)	(m)	53.98%	$411.00K*	$4.16M*	(m)	$883.00K	$4.06M	$1.54M
2014-06-30	Reported	-$1.75M	(m)	(m)	(m)	-26.39%	$253.00K*	$1.95M*	(m)	$851.00K	$5.43M	-$133.00K
2014-03-31	Reported	$4.2M	(m)	(m)	(m)	38.52%	$118.00K	$5.18M	(m)	$376.00K	$3.70M	$165.00K
2013-12-31	Reported	$3.9M	(m)	(m)	(m)	37.00%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	$1.19M	(m)	(m)	(m)	15.21%	$34.00K*	-$1.63M*	(m)	$454.00K	$3.48M	-$83.00K
2013-06-30	Reported	-$3.63M	(m)	(m)	(m)	-58.97%	$20.00K*	(m)	(m)	$437.00K	$7.17M	$0.00
2013-03-31	Reported	$548,000.00	(m)	(m)	(m)	9.85%	$108.00K	(m)	(m)	$296.00K	$2.31M	$0.00
2012-12-31	Reported	-$874,626.00	(m)	(m)	(m)	-16.44%	(m)	(m)	(m)	$2.51M	(m)	(m)
2012-09-30	Reported	-$63,442.00	(m)	(m)	(m)	-1.26%	$7.79K*	-$134.29K*	(m)	$148.65K	$1.26M	$866.00
2012-06-30	Reported	$727,063.00	(m)	(m)	(m)	14.02%	$14.86K*	(m)	(m)	$209.88K	$914.00K	$0.00
2012-03-31	Reported	-$6.90M*	-$6.93M	$30.87K	(m)	(m)	$54.23K	(m)	(m)	$5.18M	(m)	(m)
2011-12-31	Reported	(m)	-$8.34M	(m)	(m)	(m)	(m)	(m)	(m)	$6.70M	(m)	(m)
2011-09-30	Reported	-$12.99M*	-$13.03M	$35.67K	(m)	(m)	$102.68K*	-$12.58M*	(m)	$11.50M	(m)	(m)
2011-06-30	Reported	-$13.02M*	-$13.06M	$40.52K	(m)	(m)	$321.69K*	(m)	(m)	$11.12M	(m)	(m)
2011-03-31	Reported	-$16.40M*	-$16.44M	$41.94K	(m)	(m)	$221.23K	(m)	(m)	$14.86M	(m)	(m)
2010-12-31	Reported	(m)	-$13.17M	(m)	(m)	(m)	(m)	(m)	(m)	$11.90M	(m)	(m)
2010-09-30	Reported	-$11.20M*	-$11.24M	$41.00K	(m)	(m)	$5.14K*	-$10.85M*	(m)	$9.72M	(m)	(m)
2010-06-30	Reported	-$10.20M*	-$10.24M	$42.55K	(m)	(m)	(m)	(m)	(m)	$8.66M	(m)	(m)
2010-03-31	Reported	(m)	-$8.96M	(m)	(m)	(m)	(m)	(m)	(m)	$9.43M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$111.09M	(m)	$883.37M	(m)	$13.84M	$185.22M	(m)	$51.66M	$317.75M	$17.45M
2024-12-31	Reported	(m)	$584.00K	(m)	$614.38M	(m)	$16.24M	$64.02M	(m)	$44.58M	$249.64M	-$3.69M
2023-12-31	Reported	(m)	$46.97M	(m)	$486.82M	(m)	$8.87M	$118.96M	(m)	$34.29M	$161.70M	$1.09M
2022-12-31	Reported	(m)	-$35.28M	(m)	$316.38M	(m)	$8.88M	-$31.20M	(m)	$22.32M	$124.04M	-$14.77M
2021-12-31	Reported	$7.46M	(m)	(m)	(m)	3.45%	$2.56M	$3.32M	(m)	$11.37M	$84.29M	-$13.46M
2021-09-30	Rolling	(m)	-$15.74M*	(m)	$212.46M*	(m)	(m)	(m)	(m)	(m)	(m)	-$5.49M*
2021-06-30	Rolling	(m)	-$9.38M*	(m)	$213.38M*	(m)	(m)	(m)	(m)	(m)	(m)	-$3.17M*
2021-03-31	Rolling	(m)	-$5.13M*	(m)	$213.22M*	(m)	(m)	(m)	(m)	(m)	(m)	-$571.00K*
2020-12-31	Reported	$28.62M	(m)	(m)	(m)	13.73%	$6.13M	$15.27M	(m)	$16.00M	$64.99M	-$3.41M
2020-12-31	Rolling	(m)	-$16.02M*	(m)	$208.47M*	(m)	(m)	(m)	(m)	(m)	(m)	-$3.41M*
2020-09-30	Rolling	(m)	-$21.02M*	(m)	$199.19M*	(m)	(m)	(m)	(m)	(m)	(m)	-$7.48M*
2020-06-30	Rolling	(m)	-$16.49M*	(m)	$197.55M*	(m)	(m)	(m)	(m)	(m)	(m)	-$7.05M*
2020-03-31	Rolling	(m)	$4.11M*	(m)	$203.43M*	(m)	(m)	(m)	(m)	(m)	(m)	-$6.26M*
2019-12-31	Reported	$60.96M	(m)	(m)	(m)	29.52%	$6.63M	$45.63M	(m)	$19.81M	$55.84M	-$2.94M
2019-12-31	Rolling	(m)	$16.35M*	(m)	$206.55M*	(m)	(m)	(m)	(m)	(m)	(m)	-$2.94M*
2019-09-30	Rolling	(m)	$32.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$1.79M*
2019-06-30	Rolling	(m)	$35.25M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$3.06M*
2019-03-31	Rolling	(m)	$33.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$4.43M*
2018-12-31	Reported	$69.1M	(m)	(m)	(m)	34.28%	$5.74M	$67.07M	(m)	$15.39M	$44.06M	$4.56M
2018-12-31	Rolling	(m)	$35.36M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$4.56M*
2018-09-30	Rolling	(m)	$31.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$11.33M*
2018-06-30	Rolling	(m)	$30.51M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$14.31M*
2017-12-31	Reported	$56.26M	(m)	(m)	(m)	31.81%	$10.37M	$39.42M	(m)	$9.07M	$31.58M	$17.43M
2017-03-31	Rolling	(m)	$19.04M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$3.73M*
2016-12-31	Reported	$42.42M	(m)	(m)	(m)	32.98%	$4.57M	$27.47M	(m)	$2.91M	$27.83M	$4.74M
2016-12-31	Rolling	(m)	$20.08M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$4.74M*
2016-09-30	Rolling	(m)	$25.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	$25.58M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	$28.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	$39.6M	(m)	(m)	(m)	51.89%	$2.18M	$17.26M	(m)	$2.87M	$21.16M	$6.36M
2015-12-31	Rolling	(m)	$32.70M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	$37.20M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	$36.95M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	$26.08M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	$23.88M	(m)	(m)	(m)	42.67%	$1.12M	$22.03M	(m)	$2.68M	$17.93M	-$9.37M
2014-12-31	Rolling	(m)	$20.01M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	$2.01M	(m)	(m)	(m)	6.68%	$191.00K	-$5.48M	(m)	$1.71M	$16.39M	$20.00K
2013-09-30	Rolling	(m)	-$6.20M*	(m)	(m)	(m)	(m)	(m)	(m)	$3.70M*	(m)	(m)
2013-06-30	Rolling	(m)	-$7.21M*	(m)	(m)	(m)	(m)	(m)	(m)	$3.40M*	(m)	(m)
2013-03-31	Rolling	(m)	-$2.85M*	(m)	(m)	(m)	(m)	(m)	(m)	$3.17M*	(m)	(m)
2012-12-31	Reported	$525,000.00	(m)	(m)	(m)	2.58%	$292.00K	-$137.00K	(m)	$1.16M	$9.52M	-$36.00K
2012-12-31	Rolling	(m)	-$10.19M*	(m)	(m)	(m)	(m)	(m)	(m)	$8.06M*	(m)	(m)
2012-09-30	Rolling	(m)	-$14.89M*	(m)	(m)	(m)	(m)	(m)	(m)	$12.24M*	(m)	(m)
2012-06-30	Rolling	(m)	-$27.71M*	(m)	(m)	(m)	(m)	(m)	(m)	$23.59M*	(m)	(m)
2012-03-31	Rolling	(m)	-$41.37M*	(m)	(m)	(m)	(m)	(m)	(m)	$34.50M*	(m)	(m)
2011-12-31	Reported	(m)	(m)	$148.24K	(m)	(m)	$719.92K	(m)	(m)	$44.18M	(m)	$0.00
2011-12-31	Rolling	(m)	-$50.88M*	(m)	(m)	(m)	(m)	(m)	(m)	$44.18M*	(m)	(m)
2011-09-30	Rolling	(m)	-$55.70M*	(m)	(m)	(m)	(m)	(m)	(m)	$49.39M*	(m)	(m)
2011-06-30	Rolling	(m)	-$53.92M*	(m)	(m)	(m)	(m)	(m)	(m)	$47.60M*	(m)	(m)
2011-03-31	Rolling	(m)	-$51.09M*	(m)	(m)	(m)	(m)	(m)	(m)	$45.14M*	(m)	(m)
2010-12-31	Reported	(m)	(m)	$167.99K	(m)	(m)	$63.44K	(m)	(m)	$39.71M	(m)	(m)
2010-12-31	Rolling	(m)	-$43.61M*	(m)	(m)	(m)	(m)	(m)	(m)	$39.71M*	(m)	(m)
2009-12-31	Reported	(m)	(m)	$137.28K	(m)	(m)	$165.72K	(m)	(m)	$13.68M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
COMPASS Pathways plc (CMPS)		$1.812B	-4.87
Septerna, Inc. (SEPN)	United States	$1.783B	-63.01
Xencor Inc (XNCR)	United States	$1.776B	-7.33
Zymeworks Inc. (ZYME)	United States	$1.902B	-12.44
Eton Pharmaceuticals, Inc. (ETON)	United States	$1.701B	80.74
Sarepta Therapeutics, Inc. (SRPT)	United States	$1.941B	-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)	United States	$1.962B	-5.38
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82
Biohaven Ltd. (BHVN)	United States	$1.990B	-3.83